In this episode, Laura talks to Hannah Gardner about the life-extending drug Enhertu, which has just been rejected for use on the NHS in England. This means thousands of women, including Hannah, will be denied access to a drug that could’ve given them the hope of more time to live.
In this episode, Laura talks to Hannah Gardner about the life-extending drug Enhertu, which has just been rejected for use on the NHS in England. This means thousands of women, including Hannah, will be denied access to a drug that could’ve given them the hope of more time to live.
“As Lilah’s mum, I don’t want to miss one more kiss, hug, first sports day, Marvel film, whatever. I don’t want to miss one more of those than I need to. And if this drug has the potential to bring about extra life, I want that for me and I want it for all the other women too.”
Hannah
Hannah also shares how life with secondary breast cancer is for her and her 3-year-old daughter. She discusses her previous career as a clinical trials manager, and what it was like to be on the other side of the table when she joined a clinical trial herself. Hannah also describes the devastating impact of finding out she may be denied the drugs that could give her more time.
Join Hannah and Breast Cancer Now
Join Hannah and Breast Cancer Now in calling on NICE, NHS England and the drug companies Daiichi Sankyo and AstraZeneca, to do everything possible to make Enhertu available on the NHS.
Listen now on Spotify, Apple Podcasts, or wherever you get your podcasts.
You can watch this episode, and the rest of the season, on YouTube. A written transcript is also available.